Covishield-EU imbroglio: ‘I hope to resolve matter soon,’ says Serum CEO Adar Poonawalla

This follows concerns that Indian travellers who have taken the Covishield vaccine may not be eligible for the European Union’s ‘Green Pass’

Amid concerns that Indian travellers who have taken the Covishield vaccine may not be eligible for the European Union’s (EU) ‘Green Pass’, Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla on Monday said he had already taken up the matter “at the highest levels” and hoped for an early resolution of the issue. Reassuring travellers from India to EU countries, the SII CEO said in a tweet: “I realise that a lot of Indians who have taken COVISHIELD are facing issues with travel to the EU. I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries.” The SII manufactures the Oxford-AstraZeneca vaccine (with a licence from AstraZeneca) under the brand name Covishield in India.